Despite the lack of medical evidence for doing so, fertility clinics bar women over a certain BMI from their services. One writer makes the case such limits are unfair and unscientific.
Eli Lilly said the obesity medicine, which helped adults in clinical studies lose about 20% of their body weight, will be available in the U.S. by the end of the year. The list price will be $1,060.
On a trip back to her parents' native country, a writer rediscovers what makes it different. The urban design, and a culture that values longevity, make good health come al lot more naturally.
Nearly half of the people on the federal Supplemental Nutrition Assistance Program — also known as SNAP — experienced food insecurity during the pandemic. That’s up from a quarter of recipients prior to the COVID-19 outbreak.
There's already a huge demand for existing weight-loss drugs, so the new medication is highly anticipated. Obesity affects an estimated 650 million adults globally.
Maria Caprigno was one of the youngest people in the U.S. to get the surgery. As parents and doctors grapple with the obesity treatment for teens, Caprigno cites the long-term benefits.
Many eating disorder specialists oppose the new guidance's focus on weight loss and BMI, and say it minimizes the risk of disordered eating and will perpetuate deep-rooted, damaging stigmas.
As the marketing of soda and fast food ramps up around the world, the companies involved forge partnerships to help the poor. The new book 'Junk Food Politics' casts a critical eye at their efforts.
Most doctors get little training in the science of obesity or how to counsel people with the disease. As a result, many patients experience stigma in the exam room.
The new weight-loss drugs can be life-changing for people facing health conditions worsened by obesity, but price and spotty insurance coverage may keep them out of reach.